News JCR Pharmaceuticals Co., Ltd.

Equities

4552

JP3701000006

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-21 am EDT			5-day change	1st Jan Change
619 ^JPY	-2.67%		-4.48%	-47.18%

Apr. 25	JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024	CI
Mar. 21	US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）	May. 15	PU
JCR Pharmaceuticals : FY2023 Results Briefing Session -Material-（1,196KB）	May. 13	PU
JCR Pharmaceuticals : Appendix to the Consolidated Financial Summary FY2023 Second-Half (Flash report)（1,091KB）	May. 13	PU
JCR Pharmaceuticals Co., Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 27, 2024	May. 10	CI
JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024	Apr. 25	CI
Final dividend	Mar. 27	FA
US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak	Mar. 21	MT
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion	Mar. 20	MT
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	Mar. 20	AQ
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion	Mar. 19	BU
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	Mar. 19	CI
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index	Mar. 17	CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	Mar. 12	CI
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community	Feb. 29	BU
JCR Pharmaceuticals Co., Ltd. Announces Organizational and Personnel Changes	Feb. 28	CI
JCR Pharmaceuticals Research Presentations at WORLDSymposium 2024 Showcase JR-141 and Other Investigational Treatments for Lysosomal Storage Disorders	Feb. 15	AQ
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders	Feb. 14	BU
JCR Pharmaceuticals Co., Ltd. Presents Clinical Data on J-Brain Cargo®? to Deliver Medicines Across the Blood-Brain Barrier	Feb. 14	CI
JCR Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 08	CI
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024	Jan. 25	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News JCR Pharmaceuticals Co., Ltd.

Equities

4552

JP3701000006

Summary

Filters